Peroxisome proliferator-activated receptor (PPAR) α/γ dual agonist. Prepn: P. T. Cheng, WO 0121602; eidem, US 6414002 (2001, 2002 both to Bristol-Myers Squibb); P. V. Devasthale et al., J. Med. Chem. 48, 2248 (2005). Review of development and therapeutic potential: D. Barlocco, Curr. Opin. Investig. Drugs 6, 427-434 (2005).
Antidiabetic.
Antidiabetic